Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-053835

Chief Executive Officer gave up 5,219 shares (to pay taxes)

  • Chief Executive Officer acquired 19,768 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Chief Executive Officer 2022-10-13 Option exercise +3,646 150,883 D
Quart Barry D Chief Executive Officer 2022-10-13 Option exercise +16,122 167,005 D
Quart Barry D Chief Executive Officer 2022-10-13 Shares withheld for taxes −5,219 $3.76 $19,623 161,786 D
Derivatives
Quart Barry D Chief Executive Officer 2022-10-13 Option exercise · Restricted Stock Units −3,646 29,166 D
Quart Barry D Chief Executive Officer 2022-10-13 Option exercise · Restricted Stock Units −16,122 130,929 D
Loading xslF345X03/doc4.xml…